Artículos por temáticas

Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study

Holthoff V, Ferris S, Gauthier S, Ihl R, Robert P, Winblad B, Sternberg K, Tennigkeit F; ROSA Study Group.

Int J Geriatr Psychiatry. 2013 Feb;28(2):164-72. doi: 10.1002/gps.3805. Epub 2012 Apr 11.

Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease?

Brown BM, Peiffer JJ, Martins RN.

Mol Psychiatry. 2013 Aug;18(8):864-74. doi: 10.1038/mp.2012.162. Epub 2012 Nov 20.

[Active management of patients with Alzheimer disease]

Derouesné C.

Geriatr Psychol Neuropsychiatr Vieil. 2013 Sep;11(3):273-4. doi: 10.1684/pnv.2013.0420.

Current progresses on nanodelivery systems for the treatment of neuropsychiatric diseases: Alzheimer's and schizophrenia

Silva AC, González-Mira E, Lobo JM, Amaral MH.

Curr Pharm Des. 2013;19(41):7185-95. doi: 10.2174/138161281941131219123329.

Benefits of multimodal exercise intervention for postural control and frontal cognitive functions in individuals with Alzheimer's disease: a controlled trial

de Andrade LP, Gobbi LT, Coelho FG, Christofoletti G, Costa JL, Stella F.

J Am Geriatr Soc. 2013 Nov;61(11):1919-26. doi: 10.1111/jgs.12531. Epub 2013 Nov 5.

The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy: study protocol for a randomized controlled trial

Chiatti C, Masera F, Rimland JM, Cherubini A, Scarpino O, Spazzafumo L, Lattanzio F; UP-TECH research group.

Trials. 2013 May 28;14:155. doi: 10.1186/1745-6215-14-155.

Association between hospice care and psychological outcomes in Alzheimer's spousal caregivers

Irwin SA, Mausbach BT, Koo D, Fairman N, Roepke-Buehler SK, Chattillion EA, Dimsdale JE, Patterson TL, Ancoli-Israel S, Mills PJ, von Känel R, Ziegler MG, Grant I.

J Palliat Med. 2013 Nov;16(11):1450-4. doi: 10.1089/jpm.2013.0130. Epub 2013 Oct 5.

Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 - 2012)

Belluti F, Rampa A, Gobbi S, Bisi A.

Expert Opin Ther Pat. 2013 May;23(5):581-96. doi: 10.1517/13543776.2013.772983. Epub 2013 Feb 21.

Role of statins in Alzheimer's disease: a retrospective meta-analysis for commonly investigated clinical parameters in RCTs

Pandey RD, Gupta PP, Jha D, Kumar S.

Int J Neurosci. 2013 Aug;123(8):521-5. doi: 10.3109/00207454.2013.778846. Epub 2013 Apr 9.

Caregiver burden and psychosocial services in patients with early and late onset Alzheimer's disease

Grønning H, Kristiansen S, Dyre D, Rahmani A, Gyllenborg J, Høgh P.

Dan Med J. 2013 Jul;60(7):A4649.

[Development of therapies for Alzheimer's disease based on cholinergic hypothesis-status quo and future directions]

Shimohama S.

Rinsho Shinkeigaku. 2013;53(11):1036-8. doi: 10.5692/clinicalneurol.53.1036.

HtrA protease family as therapeutic targets

Skorko-Glonek J, Zurawa-Janicka D, Koper T, Jarzab M, Figaj D, Glaza P, Lipinska B.

Curr Pharm Des. 2013;19(6):977-1009. doi: 10.2174/1381612811319060003.

Is sporadic Alzheimer's disease associated with diphtheria toxin?

Merril CR.

J Alzheimers Dis. 2013;34(3):595-600. doi: 10.3233/JAD-121948.

The oxidative stress hypothesis in Alzheimer's disease

Padurariu M, Ciobica A, Lefter R, Serban IL, Stefanescu C, Chirita R.

Psychiatr Danub. 2013 Dec;25(4):401-9.

An overview of the use of music therapy in the context of Alzheimer's disease: a report of a French expert group

Guetin S, Charras K, Berard A, Arbus C, Berthelon P, Blanc F, Blayac JP, Bonte F, Bouceffa JP, Clement S, Ducourneau G, Gzil F, Laeng N, Lecourt E, Ledoux S, Platel H, Thomas-Anterion C, Touchon J, Vr

Dementia (London). 2013 Sep;12(5):619-34. doi: 10.1177/1471301212438290. Epub 2012 Mar 28.